Drp1, Dynamin-related protein 1
Legal Compliance for UK Researchers BPC-157 occupies a unique regulatory position in the UK: Not a controlled substance : No restrictions under the Misuse of Drugs Act 1971 Not a licensed medicine : Cannot be legally sold for human therapeutic use outside of clinical trials approved by the MHRA Research use permitted : Purchase and possession for laboratory research is legal Not approved for veterinary use : Administration to animals requires ethical approval and veterinary oversight under the Veterinary Medicines Regulations 2013 Reputable UK suppliers include explicit for research purposes only declarations and do not make therapeutic claims on product listingsthis demonstrates awareness of regulatory boundaries
US-based with 99%+ HPLC-verified purity, batch-specific COAs from third-party laboratories, and 5-star rating from thousands of verified customers
Observations are reported in study populations (usually animal or cell models), not guaranteed for any individual
Abraxane, formulated with albumin-bound nanoparticles and the cancer chemotherapy agent paclitaxel, is a nanomedicine within this size range that has been effective in breast cancer treatments [30,31,32]
The gap between the promising animal data and the limited human data is the most significant limitation